148 related articles for article (PubMed ID: 24294506)
21. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
22. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
Nishimura Y; Hosotani R; Shibamoto Y; Kokubo M; Kanamori S; Sasai K; Hiraoka M; Ohshio G; Imamura M; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):39-49. PubMed ID: 9300738
[TBL] [Abstract][Full Text] [Related]
23. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma.
Trinh KV; Fischer DA; Gardner TB; Smith KD
Front Oncol; 2020; 10():1461. PubMed ID: 33042792
[No Abstract] [Full Text] [Related]
26. A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer.
Lloyd S; Chang BW
J Gastrointest Oncol; 2013 Jun; 4(2):123-30. PubMed ID: 23730507
[TBL] [Abstract][Full Text] [Related]
27. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
Weinstein GD; Rich TA; Shumate CR; Skibber JM; Cleary KR; Ajani JA; Ota DM
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):197-204. PubMed ID: 7721616
[TBL] [Abstract][Full Text] [Related]
28. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
Wang G; Zhou D
Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
[TBL] [Abstract][Full Text] [Related]
29. [The Efficacy of Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer].
Sano T; Takano K; Chiba N; Tomita K; Ozawa Y; Hikita K; Shimazu M; Kawachi S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1488-90. PubMed ID: 26805072
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter.
Zhang Q; Fu S; Liu T; Peng L; Huang G; Lu JJ
Urol Oncol; 2009; 27(1):14-20. PubMed ID: 18367127
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma.
Habl G; Uhl M; Hensley F; Pahernik S; Debus J; Röder F
Radiat Oncol; 2013 Dec; 8():282. PubMed ID: 24295293
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies.
Nag S; Schuller DE; Martinez-Monge R; Rodriguez-Villalba S; Grecula J; Bauer C
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1085-9. PubMed ID: 9869233
[TBL] [Abstract][Full Text] [Related]
33. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
[TBL] [Abstract][Full Text] [Related]
34. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.
Petersen IA; Haddock MG; Donohue JH; Nagorney DM; Grill JP; Sargent DJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):469-75. PubMed ID: 11872294
[TBL] [Abstract][Full Text] [Related]
35. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome.
Cambeiro M; Calvo FA; Aristu JJ; Jimenez MM; San-Julian M; Alcalde J; Hernandez-Lizoain JL; Jurado M; Martínez-Monge R
Radiother Oncol; 2015 Aug; 116(2):316-22. PubMed ID: 26232130
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IOERT in locally advanced primary rectal cancer.
Mannaerts GH; Martijn H; Crommelin MA; Dries W; Repelaer van Driel OJ; Rutten HJ
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):425-33. PubMed ID: 10802370
[TBL] [Abstract][Full Text] [Related]
37. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer.
Sui K; Okabayashi T; Shima Y; Morita S; Iwata J; Sumiyoshi T; Saisaka Y; Hata Y; Noda Y; Matsumoto M; Nishioka A; Iiyama T; Shimada Y
Br J Radiol; 2017 Jul; 90(1075):20170165. PubMed ID: 28590776
[TBL] [Abstract][Full Text] [Related]
40. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy.
Calvo FA; Sole CV; Obregón R; Gómez-Espí M; Lozano MA; Gonzalez-Bayon L; García-Sabrido JL
Ann Surg Oncol; 2013 Jun; 20(6):1962-9. PubMed ID: 23254690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
